OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
Yang Ji, Jing Chen, Lihua Pang, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 38, Iss. 1, pp. 43-56
Open Access | Times Cited: 14
Yang Ji, Jing Chen, Lihua Pang, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 38, Iss. 1, pp. 43-56
Open Access | Times Cited: 14
Showing 14 citing articles:
The Anti-inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology
Majid Eslami, Marzieh Monemi, Masoud Nazari, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 197-197
Open Access | Times Cited: 2
Majid Eslami, Marzieh Monemi, Masoud Nazari, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 197-197
Open Access | Times Cited: 2
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
Marco Piccoli, Federica Cirillo, Andrea Ghiroldi, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 143-143
Open Access | Times Cited: 26
Marco Piccoli, Federica Cirillo, Andrea Ghiroldi, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 143-143
Open Access | Times Cited: 26
Acid sphingomyelinase promotes diabetic cardiomyopathy via NADPH oxidase 4 mediated apoptosis
Ruijiao Liu, Tengfei Duan, Yu Li, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Ruijiao Liu, Tengfei Duan, Yu Li, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 23
The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
Paola Di Pietro, Carmine Izzo, Angela Carmelita Abate, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 168-168
Open Access | Times Cited: 21
Paola Di Pietro, Carmine Izzo, Angela Carmelita Abate, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 168-168
Open Access | Times Cited: 21
Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Mai Helmy Hassan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Mai Helmy Hassan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
The Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives
Kęstutis Petrikonis, Jurga Bernatonienė, Dalia M. Kopustinskienė, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1068-1068
Open Access | Times Cited: 4
Kęstutis Petrikonis, Jurga Bernatonienė, Dalia M. Kopustinskienė, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1068-1068
Open Access | Times Cited: 4
Emerging roles of the acid sphingomyelinase/ceramide pathway in metabolic and cardiovascular diseases: Mechanistic insights and therapeutic implications
Hong-Ni Wang, Ye Wang, Siyao Zhang, et al.
World Journal of Cardiology (2025) Vol. 17, Iss. 2
Open Access
Hong-Ni Wang, Ye Wang, Siyao Zhang, et al.
World Journal of Cardiology (2025) Vol. 17, Iss. 2
Open Access
AGE induced macrophage-derived Exosomes Induce Endothelial dysfunction in diabetes via miR-22-5p/FOXP1
Yang Ji, Huanzhen Chen, Lihua Pang, et al.
Research Square (Research Square) (2025)
Closed Access
Yang Ji, Huanzhen Chen, Lihua Pang, et al.
Research Square (Research Square) (2025)
Closed Access
AGE induced macrophage-derived exosomes induce endothelial dysfunction in diabetes via miR-22-5p/FOXP1
Yang Ji, Huanzhen Chen, Lihua Pang, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Yang Ji, Huanzhen Chen, Lihua Pang, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?
Daniel Foran, Charalambos Antoniades, Ioannis Akoumianakis
(2024)
Open Access | Times Cited: 2
Daniel Foran, Charalambos Antoniades, Ioannis Akoumianakis
(2024)
Open Access | Times Cited: 2
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?
Daniel Foran, Charalambos Antoniades, Ioannis Akoumianakis
Nutrients (2024) Vol. 16, Iss. 19, pp. 3296-3296
Open Access | Times Cited: 2
Daniel Foran, Charalambos Antoniades, Ioannis Akoumianakis
Nutrients (2024) Vol. 16, Iss. 19, pp. 3296-3296
Open Access | Times Cited: 2
The therapeutic potential of sphingolipids for cardiovascular diseases
Sapir Ya’ar Bar, Noam Pintel, Hesen Abd Alghne, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Sapir Ya’ar Bar, Noam Pintel, Hesen Abd Alghne, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
A Near‐Infrared Fluorogenic Probe for Rapid, Specific, and Ultrasensitive Detection of Sphingosine in Living Cells and In Vivo
Yanyan Chen, Tingting Hao, Jing Wang, et al.
Advanced Science (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 4
Yanyan Chen, Tingting Hao, Jing Wang, et al.
Advanced Science (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 4
The protective effect of Amitriptyline on experimental colitis through inhibiting TLR4/MD2 signaling pathway
Chengcheng Zeng, Qingqing Zhu, Peng Wu, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100024-100024
Open Access | Times Cited: 1
Chengcheng Zeng, Qingqing Zhu, Peng Wu, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100024-100024
Open Access | Times Cited: 1
